US Stock MarketDetailed Quotes

MYNZ Mainz Biomed

Watchlist
  • 3.530
  • +0.330+10.31%
Close Apr 25 16:00 ET
  • 3.670
  • +0.140+3.97%
Pre 08:43 ET
10.73MMarket Cap-0.16P/E (TTM)

About Mainz Biomed Company

Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.

Company Profile

SymbolMYNZ
Company NameMainz Biomed
Listing DateNov 5, 2021
Issue Price5.00
Founded2021
CEOMr. Guido Baechler
MarketNASDAQ
Employees26
Fiscal Year Ends12-31
AddressSirius Gutenberg Park,Robert Koch Strasse 50
CityMainz
ProvinceRheinland-Pfalz
CountryGermany
Zip Code55129
Phone49-6131-265140

Company Executives

  • Name
  • Position
  • Salary
  • Guido Baechler
  • Chief Executive Officer and Director
  • --
  • William J. Caragol
  • Chief Financial Officer
  • --
  • Dr. Chris von Toerne
  • Chief Operating Officer
  • --
  • Hans Hekland
  • Independent Director
  • --
  • Gregory J. Tibbitts
  • Independent Director
  • --
  • Dr. Heiner Dreismann,PhD
  • Independent Director
  • --

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More